PDB Short entry for 5FUC HEADER IMMUNE SYSTEM 25-JAN-16 5FUC TITLE BIOPHYSICAL AND CELLULAR CHARACTERISATION OF A JUNCTIONAL EPITOPE TITLE 2 ANTIBODY THAT LOCKS IL-6 AND GP80 TOGETHER IN A STABLE COMPLEX: TITLE 3 IMPLICATIONS FOR NEW THERAPEUTIC STRATEGIES COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTERLEUKIN-6; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 49-212; COMPND 5 SYNONYM: IL-6, B-CELL STIMULATORY FACTOR 2, BSF-2, IFN-BETA-2, CTL COMPND 6 DIFFERENTIATION FACTOR, CDF, HYBRIDOMA GROWTH FACTOR, INTERFERON COMPND 7 BETA-2; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: INTERLEUKIN-6 RECEPTOR SUBUNIT ALPHA, INTERLEUKIN-6 COMPND 11 RECEPTOR; COMPND 12 CHAIN: C, D; COMPND 13 FRAGMENT: RESIDUES 20-33 AND RESIDUES 111-322; COMPND 14 SYNONYM: IL-6RA, IL-6R 1, MEMBRANE GLYCOPROTEIN 80, GP80; COMPND 15 ENGINEERED: YES; COMPND 16 MUTATION: YES; COMPND 17 MOL_ID: 3; COMPND 18 MOLECULE: VHH6; COMPND 19 CHAIN: E, V; COMPND 20 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 12 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 14 EXPRESSION_SYSTEM_CELL_LINE: HEK293; SOURCE 15 MOL_ID: 3; SOURCE 16 ORGANISM_SCIENTIFIC: CAMELUS DROMEDARIUS; SOURCE 17 ORGANISM_COMMON: CAMEL; SOURCE 18 ORGANISM_TAXID: 9838; SOURCE 19 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 20 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 21 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 22 EXPRESSION_SYSTEM_CELL_LINE: HEK293 KEYWDS VHH, IL-6, IL-6 RECEPTOR ALPHA, IL-6 RECEPTOR BETA, GP80, ANTIBODY, KEYWDS 2 JUNCTIONAL EPITOPE, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR R.ADAMS,R.GRIFFIN,C.DOYLE,A.ETTORRE REVDAT 5 10-JAN-24 5FUC 1 REMARK HETSYN REVDAT 4 29-JUL-20 5FUC 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE REVDAT 3 03-APR-19 5FUC 1 SOURCE REMARK LINK REVDAT 2 01-MAR-17 5FUC 1 JRNL REVDAT 1 25-JAN-17 5FUC 0 JRNL AUTH R.ADAMS,R.J.BURNLEY,C.R.VALENZANO,O.QURESHI,C.DOYLE,S.LUMB, JRNL AUTH 2 M.DEL CARMEN LOPEZ,R.GRIFFIN,D.MCMILLAN,R.D.TAYLOR,C.MEIER, JRNL AUTH 3 P.MORI,L.M.GRIFFIN,U.WERNERY,J.KINNE,S.RAPECKI,T.S.BAKER, JRNL AUTH 4 A.D.LAWSON,M.WRIGHT,A.ETTORRE JRNL TITL DISCOVERY OF A JUNCTIONAL EPITOPE ANTIBODY THAT STABILIZES JRNL TITL 2 IL-6 AND GP80 PROTEIN:PROTEIN INTERACTION AND MODULATES ITS JRNL TITL 3 DOWNSTREAM SIGNALING. JRNL REF SCI REP V. 7 37716 2017 JRNL REFN ESSN 2045-2322 JRNL PMID 28134246 JRNL DOI 10.1038/SREP37716 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.3 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 34870 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.231 REMARK 3 FREE R VALUE : 0.287 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.900 REMARK 3 FREE R VALUE TEST SET COUNT : 3461 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.80 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3117 REMARK 3 BIN R VALUE (WORKING SET) : 0.4176 REMARK 3 BIN FREE R VALUE : 0.4847 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 342 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.026 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7505 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 111 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.76400 REMARK 3 B22 (A**2) : -3.66600 REMARK 3 B33 (A**2) : 2.90200 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -2.07900 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE FOLLOWING REGIONS WERE TOO REMARK 3 DISORDERED TO MODEL, CHAIN A RESIDUES 52 TO 62, 131 TO 133, REMARK 3 CHAIN B RESIDUES 19 AND 20, 132 TO 135, CHAIN C RESIDUES 73 TO REMARK 3 97, 138, 298 TO 303, CHAIN D RESIDUES 73 TO 91, 134 TO 140, 299 REMARK 3 TO 303, CHAIN E RESIDUES 1 AND 2, 8 TO 16, 121 TO 132, CHAIN V REMARK 3 RESIDUES 125 TO 132 REMARK 4 REMARK 4 5FUC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 25-JAN-16. REMARK 100 THE DEPOSITION ID IS D_1290065947. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-SEP-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SOLEIL REMARK 200 BEAMLINE : PROXIMA 1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97857 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18151 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.690 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 7.500 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 20.8800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.69 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.9 REMARK 200 DATA REDUNDANCY IN SHELL : 7.50 REMARK 200 R MERGE FOR SHELL (I) : 0.50000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.970 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1P9M, VHH IN-HOUSE STRUCTURE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M MES, PH 6.5, 14% PEG20K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 124.51500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.90000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 124.51500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 33.90000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 4360 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 31000 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D, V REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 3680 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 35330 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.8 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 52 REMARK 465 SER A 53 REMARK 465 LYS A 54 REMARK 465 GLU A 55 REMARK 465 ALA A 56 REMARK 465 LEU A 57 REMARK 465 ALA A 58 REMARK 465 GLU A 59 REMARK 465 ASN A 60 REMARK 465 ASN A 61 REMARK 465 LEU A 62 REMARK 465 LYS A 131 REMARK 465 ASN A 132 REMARK 465 LEU A 133 REMARK 465 GLY B 19 REMARK 465 SER B 20 REMARK 465 ASN B 132 REMARK 465 LEU B 133 REMARK 465 ASP B 134 REMARK 465 ALA B 135 REMARK 465 GLY C 73 REMARK 465 LEU C 74 REMARK 465 ALA C 75 REMARK 465 PRO C 76 REMARK 465 ARG C 77 REMARK 465 ARG C 78 REMARK 465 CYS C 79 REMARK 465 PRO C 80 REMARK 465 ALA C 81 REMARK 465 GLN C 82 REMARK 465 GLU C 83 REMARK 465 VAL C 84 REMARK 465 ALA C 85 REMARK 465 ARG C 86 REMARK 465 GLY C 87 REMARK 465 ALA C 88 REMARK 465 GLY C 89 REMARK 465 ALA C 90 REMARK 465 GLY C 91 REMARK 465 ASP C 92 REMARK 465 VAL C 93 REMARK 465 PRO C 94 REMARK 465 PRO C 95 REMARK 465 GLU C 96 REMARK 465 GLU C 97 REMARK 465 PRO C 138 REMARK 465 GLU C 298 REMARK 465 SER C 299 REMARK 465 ARG C 300 REMARK 465 SER C 301 REMARK 465 PRO C 302 REMARK 465 PRO C 303 REMARK 465 GLY D 73 REMARK 465 LEU D 74 REMARK 465 ALA D 75 REMARK 465 PRO D 76 REMARK 465 ARG D 77 REMARK 465 ARG D 78 REMARK 465 CYS D 79 REMARK 465 PRO D 80 REMARK 465 ALA D 81 REMARK 465 GLN D 82 REMARK 465 GLU D 83 REMARK 465 VAL D 84 REMARK 465 ALA D 85 REMARK 465 ARG D 86 REMARK 465 GLY D 87 REMARK 465 ALA D 88 REMARK 465 GLY D 89 REMARK 465 ALA D 90 REMARK 465 GLY D 91 REMARK 465 ASP D 92 REMARK 465 VAL D 93 REMARK 465 PHE D 134 REMARK 465 GLN D 135 REMARK 465 ASN D 136 REMARK 465 SER D 137 REMARK 465 PRO D 138 REMARK 465 ALA D 139 REMARK 465 GLU D 140 REMARK 465 SER D 299 REMARK 465 ARG D 300 REMARK 465 SER D 301 REMARK 465 PRO D 302 REMARK 465 PRO D 303 REMARK 465 ASP E 1 REMARK 465 VAL E 2 REMARK 465 GLY E 9 REMARK 465 GLY E 10 REMARK 465 SER E 11 REMARK 465 VAL E 12 REMARK 465 HIS E 13 REMARK 465 ALA E 14 REMARK 465 GLY E 15 REMARK 465 GLY E 16 REMARK 465 VAL E 121 REMARK 465 THR E 122 REMARK 465 VAL E 123 REMARK 465 SER E 124 REMARK 465 SER E 125 REMARK 465 ARG E 126 REMARK 465 GLU E 127 REMARK 465 ASN E 128 REMARK 465 LEU E 129 REMARK 465 TYR E 130 REMARK 465 PHE E 131 REMARK 465 GLN E 132 REMARK 465 SER V 125 REMARK 465 ARG V 126 REMARK 465 GLU V 127 REMARK 465 ASN V 128 REMARK 465 LEU V 129 REMARK 465 TYR V 130 REMARK 465 PHE V 131 REMARK 465 GLN V 132 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 66 CG CD CE NZ REMARK 470 GLU A 69 CB CG CD OE1 OE2 REMARK 470 GLU A 109 CB CG CD OE1 OE2 REMARK 470 GLU A 110 CB CG CD OE1 OE2 REMARK 470 LYS A 128 CG CD CE NZ REMARK 470 LYS C 244 CG CD CE NZ REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LEU E 86 CB CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 48 43.50 -97.19 REMARK 500 CYS A 50 -63.40 -104.44 REMARK 500 SER A 108 64.04 -108.14 REMARK 500 GLN A 154 156.91 -47.19 REMARK 500 CYS B 50 -102.37 -131.08 REMARK 500 GLU B 51 -28.09 -32.93 REMARK 500 SER B 52 101.42 78.69 REMARK 500 LEU B 62 -44.26 63.43 REMARK 500 LEU C 123 -34.83 69.33 REMARK 500 THR C 125 56.17 -67.98 REMARK 500 GLN C 135 -85.82 -111.33 REMARK 500 PHE C 142 -148.93 -91.59 REMARK 500 GLN C 150 -20.06 72.18 REMARK 500 ALA C 209 134.62 -38.84 REMARK 500 ARG C 210 31.87 71.86 REMARK 500 ASN C 211 80.01 -159.62 REMARK 500 PRO C 212 4.06 -63.79 REMARK 500 LYS C 252 -73.11 -22.88 REMARK 500 ASP C 253 -135.81 -133.76 REMARK 500 HIS C 256 37.44 -93.64 REMARK 500 SER C 265 132.16 -37.38 REMARK 500 GLU C 278 -35.44 -39.79 REMARK 500 GLU D 97 107.30 -48.78 REMARK 500 THR D 120 135.11 -29.56 REMARK 500 LEU D 123 24.66 -79.56 REMARK 500 PRO D 162 153.85 -44.13 REMARK 500 GLN D 196 88.96 -162.28 REMARK 500 ALA D 209 121.59 -14.42 REMARK 500 TRP D 225 65.22 -113.23 REMARK 500 LYS D 252 -72.57 -30.60 REMARK 500 ASP D 253 -135.83 -136.03 REMARK 500 HIS D 256 48.86 -85.54 REMARK 500 ALA D 258 147.71 -171.35 REMARK 500 SER D 265 137.04 -39.61 REMARK 500 SER E 7 144.92 -178.22 REMARK 500 LEU E 18 108.43 -176.48 REMARK 500 CYS E 22 95.14 -170.77 REMARK 500 VAL E 48 -64.34 -125.50 REMARK 500 SER E 63 3.66 -59.46 REMARK 500 VAL E 64 -11.45 -141.59 REMARK 500 LYS E 65 162.07 -40.19 REMARK 500 ARG E 67 -75.42 -74.16 REMARK 500 LEU E 81 83.16 -178.97 REMARK 500 THR E 91 107.65 -11.85 REMARK 500 ALA E 92 -162.71 178.76 REMARK 500 ILE E 102 40.56 -83.61 REMARK 500 ARG E 103 11.00 -150.62 REMARK 500 ASP E 114 142.17 -172.80 REMARK 500 SER V 7 171.17 170.70 REMARK 500 VAL V 48 -72.90 -112.85 REMARK 500 REMARK 500 THIS ENTRY HAS 52 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5FUO RELATED DB: PDB REMARK 900 EXTENDING THE HALF-LIFE OF A FAB FRAGMENT THROUGH GENERATION OF A REMARK 900 HUMANISED ANTI-HUMAN SERUM ALBUMIN ( HSA) FV DOMAIN: AN REMARK 900 INVESTIGATION INTO THE CORRELATION BETWEEN AFFINITY AND SERUM HALF- REMARK 900 LIFE REMARK 900 RELATED ID: 5FUZ RELATED DB: PDB REMARK 900 EXTENDING THE HALF-LIFE OF A FAB FRAGMENT THROUGH GENERATION OF A REMARK 900 HUMANISED ANTI-HUMAN SERUM ALBUMIN ( HSA) FV DOMAIN: AN REMARK 900 INVESTIGATION INTO THE CORRELATION BETWEEN AFFINITY AND SERUM HALF- REMARK 900 LIFE REMARK 999 REMARK 999 SEQUENCE REMARK 999 CYS 192 MUTATED TO SER, CYS 258 MUTATED TO ALA. THE FIRST REMARK 999 19 RESIDUES ARE FROM DOMAIN 1 OF IL-6. THE REST OF THE REMARK 999 SEQUENCE IS DOMAIN 3. REMARK 999 RENLYFQ IS REMAINDER OF TEV CLEAVAGE SITE VHH6 IS INTERNAL REMARK 999 DISCOVERY DBREF 5FUC A 21 184 UNP P05231 IL6_HUMAN 49 212 DBREF 5FUC B 21 184 UNP P05231 IL6_HUMAN 49 212 DBREF 5FUC C 74 87 UNP D6R9R8 D6R9R8_HUMAN 20 33 DBREF 5FUC C 92 303 UNP P08887 IL6RA_HUMAN 111 322 DBREF 5FUC D 74 87 UNP D6R9R8 D6R9R8_HUMAN 20 33 DBREF 5FUC D 92 303 UNP P08887 IL6RA_HUMAN 111 322 DBREF 5FUC E 1 132 PDB 5FUC 5FUC 1 132 DBREF 5FUC V 1 132 PDB 5FUC 5FUC 1 132 SEQADV 5FUC GLY A 19 UNP P05231 EXPRESSION TAG SEQADV 5FUC SER A 20 UNP P05231 EXPRESSION TAG SEQADV 5FUC GLY B 19 UNP P05231 EXPRESSION TAG SEQADV 5FUC SER B 20 UNP P05231 EXPRESSION TAG SEQADV 5FUC GLY C 73 UNP D6R9R8 EXPRESSION TAG SEQADV 5FUC ALA C 88 UNP D6R9R8 LINKER SEQADV 5FUC GLY C 89 UNP D6R9R8 LINKER SEQADV 5FUC ALA C 90 UNP D6R9R8 LINKER SEQADV 5FUC GLY C 91 UNP D6R9R8 LINKER SEQADV 5FUC ALA C 192 UNP P08887 CYS 211 ENGINEERED MUTATION SEQADV 5FUC ALA C 258 UNP P08887 CYS 277 ENGINEERED MUTATION SEQADV 5FUC GLY D 73 UNP D6R9R8 EXPRESSION TAG SEQADV 5FUC ALA D 88 UNP D6R9R8 LINKER SEQADV 5FUC GLY D 89 UNP D6R9R8 LINKER SEQADV 5FUC ALA D 90 UNP D6R9R8 LINKER SEQADV 5FUC GLY D 91 UNP D6R9R8 LINKER SEQADV 5FUC ALA D 192 UNP P08887 CYS 211 ENGINEERED MUTATION SEQADV 5FUC ALA D 258 UNP P08887 CYS 277 ENGINEERED MUTATION SEQRES 1 A 166 GLY SER SER SER GLU ARG ILE ASP LYS GLN ILE ARG TYR SEQRES 2 A 166 ILE LEU ASP GLY ILE SER ALA LEU ARG LYS GLU THR CYS SEQRES 3 A 166 ASN LYS SER ASN MET CYS GLU SER SER LYS GLU ALA LEU SEQRES 4 A 166 ALA GLU ASN ASN LEU ASN LEU PRO LYS MET ALA GLU LYS SEQRES 5 A 166 ASP GLY CYS PHE GLN SER GLY PHE ASN GLU GLU THR CYS SEQRES 6 A 166 LEU VAL LYS ILE ILE THR GLY LEU LEU GLU PHE GLU VAL SEQRES 7 A 166 TYR LEU GLU TYR LEU GLN ASN ARG PHE GLU SER SER GLU SEQRES 8 A 166 GLU GLN ALA ARG ALA VAL GLN MET SER THR LYS VAL LEU SEQRES 9 A 166 ILE GLN PHE LEU GLN LYS LYS ALA LYS ASN LEU ASP ALA SEQRES 10 A 166 ILE THR THR PRO ASP PRO THR THR ASN ALA SER LEU LEU SEQRES 11 A 166 THR LYS LEU GLN ALA GLN ASN GLN TRP LEU GLN ASP MET SEQRES 12 A 166 THR THR HIS LEU ILE LEU ARG SER PHE LYS GLU PHE LEU SEQRES 13 A 166 GLN SER SER LEU ARG ALA LEU ARG GLN MET SEQRES 1 B 166 GLY SER SER SER GLU ARG ILE ASP LYS GLN ILE ARG TYR SEQRES 2 B 166 ILE LEU ASP GLY ILE SER ALA LEU ARG LYS GLU THR CYS SEQRES 3 B 166 ASN LYS SER ASN MET CYS GLU SER SER LYS GLU ALA LEU SEQRES 4 B 166 ALA GLU ASN ASN LEU ASN LEU PRO LYS MET ALA GLU LYS SEQRES 5 B 166 ASP GLY CYS PHE GLN SER GLY PHE ASN GLU GLU THR CYS SEQRES 6 B 166 LEU VAL LYS ILE ILE THR GLY LEU LEU GLU PHE GLU VAL SEQRES 7 B 166 TYR LEU GLU TYR LEU GLN ASN ARG PHE GLU SER SER GLU SEQRES 8 B 166 GLU GLN ALA ARG ALA VAL GLN MET SER THR LYS VAL LEU SEQRES 9 B 166 ILE GLN PHE LEU GLN LYS LYS ALA LYS ASN LEU ASP ALA SEQRES 10 B 166 ILE THR THR PRO ASP PRO THR THR ASN ALA SER LEU LEU SEQRES 11 B 166 THR LYS LEU GLN ALA GLN ASN GLN TRP LEU GLN ASP MET SEQRES 12 B 166 THR THR HIS LEU ILE LEU ARG SER PHE LYS GLU PHE LEU SEQRES 13 B 166 GLN SER SER LEU ARG ALA LEU ARG GLN MET SEQRES 1 C 231 GLY LEU ALA PRO ARG ARG CYS PRO ALA GLN GLU VAL ALA SEQRES 2 C 231 ARG GLY ALA GLY ALA GLY ASP VAL PRO PRO GLU GLU PRO SEQRES 3 C 231 GLN LEU SER CYS PHE ARG LYS SER PRO LEU SER ASN VAL SEQRES 4 C 231 VAL CYS GLU TRP GLY PRO ARG SER THR PRO SER LEU THR SEQRES 5 C 231 THR LYS ALA VAL LEU LEU VAL ARG LYS PHE GLN ASN SER SEQRES 6 C 231 PRO ALA GLU ASP PHE GLN GLU PRO CYS GLN TYR SER GLN SEQRES 7 C 231 GLU SER GLN LYS PHE SER CYS GLN LEU ALA VAL PRO GLU SEQRES 8 C 231 GLY ASP SER SER PHE TYR ILE VAL SER MET CYS VAL ALA SEQRES 9 C 231 SER SER VAL GLY SER LYS PHE SER LYS THR GLN THR PHE SEQRES 10 C 231 GLN GLY ALA GLY ILE LEU GLN PRO ASP PRO PRO ALA ASN SEQRES 11 C 231 ILE THR VAL THR ALA VAL ALA ARG ASN PRO ARG TRP LEU SEQRES 12 C 231 SER VAL THR TRP GLN ASP PRO HIS SER TRP ASN SER SER SEQRES 13 C 231 PHE TYR ARG LEU ARG PHE GLU LEU ARG TYR ARG ALA GLU SEQRES 14 C 231 ARG SER LYS THR PHE THR THR TRP MET VAL LYS ASP LEU SEQRES 15 C 231 GLN HIS HIS ALA VAL ILE HIS ASP ALA TRP SER GLY LEU SEQRES 16 C 231 ARG HIS VAL VAL GLN LEU ARG ALA GLN GLU GLU PHE GLY SEQRES 17 C 231 GLN GLY GLU TRP SER GLU TRP SER PRO GLU ALA MET GLY SEQRES 18 C 231 THR PRO TRP THR GLU SER ARG SER PRO PRO SEQRES 1 D 231 GLY LEU ALA PRO ARG ARG CYS PRO ALA GLN GLU VAL ALA SEQRES 2 D 231 ARG GLY ALA GLY ALA GLY ASP VAL PRO PRO GLU GLU PRO SEQRES 3 D 231 GLN LEU SER CYS PHE ARG LYS SER PRO LEU SER ASN VAL SEQRES 4 D 231 VAL CYS GLU TRP GLY PRO ARG SER THR PRO SER LEU THR SEQRES 5 D 231 THR LYS ALA VAL LEU LEU VAL ARG LYS PHE GLN ASN SER SEQRES 6 D 231 PRO ALA GLU ASP PHE GLN GLU PRO CYS GLN TYR SER GLN SEQRES 7 D 231 GLU SER GLN LYS PHE SER CYS GLN LEU ALA VAL PRO GLU SEQRES 8 D 231 GLY ASP SER SER PHE TYR ILE VAL SER MET CYS VAL ALA SEQRES 9 D 231 SER SER VAL GLY SER LYS PHE SER LYS THR GLN THR PHE SEQRES 10 D 231 GLN GLY ALA GLY ILE LEU GLN PRO ASP PRO PRO ALA ASN SEQRES 11 D 231 ILE THR VAL THR ALA VAL ALA ARG ASN PRO ARG TRP LEU SEQRES 12 D 231 SER VAL THR TRP GLN ASP PRO HIS SER TRP ASN SER SER SEQRES 13 D 231 PHE TYR ARG LEU ARG PHE GLU LEU ARG TYR ARG ALA GLU SEQRES 14 D 231 ARG SER LYS THR PHE THR THR TRP MET VAL LYS ASP LEU SEQRES 15 D 231 GLN HIS HIS ALA VAL ILE HIS ASP ALA TRP SER GLY LEU SEQRES 16 D 231 ARG HIS VAL VAL GLN LEU ARG ALA GLN GLU GLU PHE GLY SEQRES 17 D 231 GLN GLY GLU TRP SER GLU TRP SER PRO GLU ALA MET GLY SEQRES 18 D 231 THR PRO TRP THR GLU SER ARG SER PRO PRO SEQRES 1 E 132 ASP VAL GLN PHE VAL GLU SER GLY GLY GLY SER VAL HIS SEQRES 2 E 132 ALA GLY GLY SER LEU ARG LEU ASN CYS ALA THR SER GLY SEQRES 3 E 132 TYR ILE TYR SER THR TYR CYS MET GLY TRP PHE ARG GLN SEQRES 4 E 132 ALA PRO GLY LYS GLU ARG GLU GLY VAL ALA HIS ILE TYR SEQRES 5 E 132 THR ASN SER GLY ARG THR TYR TYR ALA ASP SER VAL LYS SEQRES 6 E 132 GLY ARG PHE THR ILE SER GLN ASP ASN ALA LYS ASN THR SEQRES 7 E 132 VAL TYR LEU GLN MET ASN SER LEU LYS PRO GLU ASP THR SEQRES 8 E 132 ALA ILE TYR TYR CYS ALA ALA ARG PRO SER ILE ARG CYS SEQRES 9 E 132 ALA SER PHE SER ALA THR GLU TYR LYS ASP TRP GLY GLN SEQRES 10 E 132 GLY THR GLN VAL THR VAL SER SER ARG GLU ASN LEU TYR SEQRES 11 E 132 PHE GLN SEQRES 1 V 132 ASP VAL GLN PHE VAL GLU SER GLY GLY GLY SER VAL HIS SEQRES 2 V 132 ALA GLY GLY SER LEU ARG LEU ASN CYS ALA THR SER GLY SEQRES 3 V 132 TYR ILE TYR SER THR TYR CYS MET GLY TRP PHE ARG GLN SEQRES 4 V 132 ALA PRO GLY LYS GLU ARG GLU GLY VAL ALA HIS ILE TYR SEQRES 5 V 132 THR ASN SER GLY ARG THR TYR TYR ALA ASP SER VAL LYS SEQRES 6 V 132 GLY ARG PHE THR ILE SER GLN ASP ASN ALA LYS ASN THR SEQRES 7 V 132 VAL TYR LEU GLN MET ASN SER LEU LYS PRO GLU ASP THR SEQRES 8 V 132 ALA ILE TYR TYR CYS ALA ALA ARG PRO SER ILE ARG CYS SEQRES 9 V 132 ALA SER PHE SER ALA THR GLU TYR LYS ASP TRP GLY GLN SEQRES 10 V 132 GLY THR GLN VAL THR VAL SER SER ARG GLU ASN LEU TYR SEQRES 11 V 132 PHE GLN MODRES 5FUC ASN C 202 ASN GLYCOSYLATION SITE MODRES 5FUC ASN C 226 ASN GLYCOSYLATION SITE MODRES 5FUC ASN D 202 ASN GLYCOSYLATION SITE MODRES 5FUC ASN D 226 ASN GLYCOSYLATION SITE HET NAG C1298 14 HET NAG C1299 14 HET NAG D1299 14 HET NAG D1300 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 7 NAG 4(C8 H15 N O6) FORMUL 11 HOH *111(H2 O) HELIX 1 1 SER A 20 LYS A 46 1 27 HELIX 2 2 ALA A 68 GLY A 72 5 5 HELIX 3 3 ASN A 79 GLN A 102 1 24 HELIX 4 4 SER A 108 LYS A 128 1 21 HELIX 5 5 ASP A 140 GLN A 154 1 15 HELIX 6 6 ASN A 155 GLN A 183 1 29 HELIX 7 7 SER B 21 SER B 47 1 27 HELIX 8 8 ALA B 68 GLY B 72 5 5 HELIX 9 9 ASN B 79 GLN B 102 1 24 HELIX 10 10 SER B 108 ALA B 130 1 23 HELIX 11 11 ASP B 140 GLN B 152 1 13 HELIX 12 12 ASN B 155 ARG B 182 1 28 HELIX 13 13 ALA C 192 ILE C 194 5 3 HELIX 14 14 SER E 25 TYR E 32 1 8 HELIX 15 15 ASP E 62 LYS E 65 5 4 HELIX 16 16 PRO E 100 CYS E 104 5 5 HELIX 17 17 SER V 25 TYR V 32 1 8 HELIX 18 18 ASN V 74 LYS V 76 5 3 HELIX 19 19 LYS V 87 THR V 91 5 5 HELIX 20 20 PRO V 100 CYS V 104 5 5 HELIX 21 21 SER V 108 TYR V 112 5 5 SHEET 1 CA 7 SER C 101 PHE C 103 0 SHEET 2 CA 7 VAL C 111 TRP C 115 -1 O VAL C 112 N PHE C 103 SHEET 3 CA 7 PHE C 155 LEU C 159 -1 O PHE C 155 N TRP C 115 SHEET 4 CA 7 GLN C 143 TYR C 148 -1 O PRO C 145 N GLN C 158 SHEET 5 CA 7 ALA C 127 PHE C 134 -1 O ALA C 127 N CYS C 146 SHEET 6 CA 7 PHE C 168 VAL C 175 -1 O PHE C 168 N PHE C 134 SHEET 7 CA 7 GLN C 187 GLN C 190 -1 O GLN C 187 N VAL C 171 SHEET 1 CB 3 ALA C 201 THR C 206 0 SHEET 2 CB 3 LEU C 215 GLN C 220 -1 O SER C 216 N THR C 206 SHEET 3 CB 3 HIS C 257 ILE C 260 -1 O ALA C 258 N VAL C 217 SHEET 1 CC 4 THR C 247 MET C 250 0 SHEET 2 CC 4 LEU C 232 ALA C 240 -1 O LEU C 236 N TRP C 249 SHEET 3 CC 4 HIS C 269 GLU C 277 -1 O VAL C 270 N ARG C 239 SHEET 4 CC 4 ALA C 291 GLY C 293 -1 O ALA C 291 N VAL C 271 SHEET 1 DA 7 SER D 101 PHE D 103 0 SHEET 2 DA 7 VAL D 111 TRP D 115 -1 O VAL D 112 N PHE D 103 SHEET 3 DA 7 PHE D 155 LEU D 159 -1 O PHE D 155 N TRP D 115 SHEET 4 DA 7 GLN D 143 TYR D 148 -1 O PRO D 145 N GLN D 158 SHEET 5 DA 7 LYS D 126 ARG D 132 -1 O ALA D 127 N CYS D 146 SHEET 6 DA 7 TYR D 169 ALA D 176 -1 O ILE D 170 N ARG D 132 SHEET 7 DA 7 SER D 181 LYS D 182 1 O LYS D 182 N VAL D 175 SHEET 1 DB 7 SER D 101 PHE D 103 0 SHEET 2 DB 7 VAL D 111 TRP D 115 -1 O VAL D 112 N PHE D 103 SHEET 3 DB 7 PHE D 155 LEU D 159 -1 O PHE D 155 N TRP D 115 SHEET 4 DB 7 GLN D 143 TYR D 148 -1 O PRO D 145 N GLN D 158 SHEET 5 DB 7 LYS D 126 ARG D 132 -1 O ALA D 127 N CYS D 146 SHEET 6 DB 7 TYR D 169 ALA D 176 -1 O ILE D 170 N ARG D 132 SHEET 7 DB 7 GLN D 187 PHE D 189 -1 O GLN D 187 N VAL D 171 SHEET 1 DC 2 SER D 181 LYS D 182 0 SHEET 2 DC 2 TYR D 169 ALA D 176 1 O VAL D 175 N LYS D 182 SHEET 1 DD 3 ALA D 201 THR D 206 0 SHEET 2 DD 3 LEU D 215 GLN D 220 -1 O SER D 216 N THR D 206 SHEET 3 DD 3 HIS D 257 ILE D 260 -1 O ALA D 258 N VAL D 217 SHEET 1 DE 4 THR D 247 MET D 250 0 SHEET 2 DE 4 LEU D 232 ALA D 240 -1 O LEU D 236 N TRP D 249 SHEET 3 DE 4 HIS D 269 GLU D 277 -1 O VAL D 270 N ARG D 239 SHEET 4 DE 4 ALA D 291 GLY D 293 -1 O ALA D 291 N VAL D 271 SHEET 1 EA 2 VAL E 5 SER E 7 0 SHEET 2 EA 2 ASN E 21 ALA E 23 -1 O ASN E 21 N SER E 7 SHEET 1 EB 5 THR E 58 TYR E 60 0 SHEET 2 EB 5 ALA E 49 ILE E 51 -1 O HIS E 50 N TYR E 59 SHEET 3 EB 5 CYS E 33 TRP E 36 -1 O MET E 34 N ILE E 51 SHEET 4 EB 5 CYS E 96 ARG E 99 -1 O ALA E 97 N GLY E 35 SHEET 5 EB 5 ASP E 114 TRP E 115 -1 O ASP E 114 N ALA E 98 SHEET 1 EC 2 PHE E 68 THR E 69 0 SHEET 2 EC 2 GLN E 82 MET E 83 -1 O GLN E 82 N THR E 69 SHEET 1 ED 2 GLN E 72 ASP E 73 0 SHEET 2 ED 2 THR E 78 VAL E 79 -1 O THR E 78 N ASP E 73 SHEET 1 VA 4 PHE V 4 SER V 7 0 SHEET 2 VA 4 LEU V 18 THR V 24 -1 O ASN V 21 N SER V 7 SHEET 3 VA 4 THR V 78 MET V 83 -1 O VAL V 79 N CYS V 22 SHEET 4 VA 4 PHE V 68 ASP V 73 -1 O THR V 69 N GLN V 82 SHEET 1 VB 4 GLY V 10 HIS V 13 0 SHEET 2 VB 4 THR V 119 SER V 124 1 O GLN V 120 N GLY V 10 SHEET 3 VB 4 ALA V 92 ARG V 99 -1 O ALA V 92 N VAL V 121 SHEET 4 VB 4 ASP V 114 TRP V 115 -1 O ASP V 114 N ALA V 98 SHEET 1 VC 6 GLY V 10 HIS V 13 0 SHEET 2 VC 6 THR V 119 SER V 124 1 O GLN V 120 N GLY V 10 SHEET 3 VC 6 ALA V 92 ARG V 99 -1 O ALA V 92 N VAL V 121 SHEET 4 VC 6 CYS V 33 GLN V 39 -1 O CYS V 33 N ARG V 99 SHEET 5 VC 6 GLU V 46 ILE V 51 -1 O GLU V 46 N ARG V 38 SHEET 6 VC 6 THR V 58 TYR V 60 -1 O TYR V 59 N HIS V 50 SHEET 1 VD 2 ASP V 114 TRP V 115 0 SHEET 2 VD 2 ALA V 92 ARG V 99 -1 N ALA V 98 O ASP V 114 SSBOND 1 CYS A 44 CYS A 50 1555 1555 2.04 SSBOND 2 CYS A 73 CYS A 83 1555 1555 2.03 SSBOND 3 CYS B 44 CYS B 50 1555 1555 2.05 SSBOND 4 CYS B 73 CYS B 83 1555 1555 2.04 SSBOND 5 CYS C 102 CYS C 113 1555 1555 2.05 SSBOND 6 CYS C 146 CYS C 157 1555 1555 2.05 SSBOND 7 CYS D 102 CYS D 113 1555 1555 2.04 SSBOND 8 CYS D 146 CYS D 157 1555 1555 2.04 SSBOND 9 CYS E 22 CYS E 96 1555 1555 2.03 SSBOND 10 CYS E 33 CYS E 104 1555 1555 2.05 SSBOND 11 CYS V 22 CYS V 96 1555 1555 2.04 SSBOND 12 CYS V 33 CYS V 104 1555 1555 2.05 LINK ND2 ASN C 202 C1 NAG C1298 1555 1555 1.45 LINK ND2 ASN C 226 C1 NAG C1299 1555 1555 1.45 LINK ND2 ASN D 202 C1 NAG D1299 1555 1555 1.45 LINK ND2 ASN D 226 C1 NAG D1300 1555 1555 1.46 CRYST1 249.030 67.800 78.160 90.00 104.53 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004016 0.000000 0.001041 0.00000 SCALE2 0.000000 0.014749 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013217 0.00000